Position in PFE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$55,733,911
+$9,861,265 QoQ
Shares Held
1,984,826
+7.7% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $1,669,332,547 across 17 Drug Manufacturers - General names. PFE ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
503,731 | $463,316,658 | |
| 2 | JNJ |
Johnson & Johnson
|
1,054,990 | $257,881,753 | |
| 3 | AMGN |
Amgen Inc
|
643,944 | $226,571,694 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,752,898 | $210,856,097 | |
| 5 | ABBV |
AbbVie Inc.
|
911,994 | $198,349,572 | |
| 6 | AZN |
Astrazeneca PLC
|
473,389 | $93,361,776 | |
| 7 | PFE |
Pfizer Inc
This page
|
1,984,826 | $55,733,911 | |
| 8 | NVO |
Novo Nordisk A S
|
1,433,073 | $52,665,431 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,733,911 | 1,984,826 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $45,872,646 | 1,842,275 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $36,929,741 | 1,449,362 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $32,450,740 | 1,338,727 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,327,015 | 1,709,827 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $44,183,166 | 1,665,404 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $47,174,774 | 1,630,089 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $44,699,866 | 1,597,565 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $48,038,468 | 1,731,116 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $64,748,189 | 2,248,982 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $73,144,359 | 2,205,136 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $76,441,559 | 2,084,012 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $81,627,865 | 2,000,683 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $105,580,736 | 2,060,514 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $66,194,132 | 1,512,663 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $75,005,360 | 1,430,581 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $65,803,965 | 1,271,083 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $67,765,247 | 1,147,591 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $48,228,058 | 1,121,322 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $38,386,823 | 980,256 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $31,853,305 | 879,197 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $32,926,948 | 894,511 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $27,292,917 | 743,677 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,078,865 | 675,194 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $24,960,882 | 764,734 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||